PDB Short entry for 3OYP HEADER HYDROLASE/HYDROLASE INHIBITOR 23-SEP-10 3OYP TITLE HCV NS3/4A IN COMPLEX WITH LIGAND 3 COMPND MOL_ID: 1; COMPND 2 MOLECULE: SERINE PROTEASE NS3; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: PROTEASE/HELICASE NS3 (P70), UNP RESIDUES 1027-1213; COMPND 5 SYNONYM: HEPACIVIRIN, NS3P, P70; COMPND 6 EC: 3.4.21.98, 3.6.1.15, 3.6.4.13; COMPND 7 ENGINEERED: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: NON-STRUCTURAL PROTEIN 4A; COMPND 10 CHAIN: C, D; COMPND 11 FRAGMENT: NONSTRUCTURAL PROTEIN NS4A (P4), UNP RESIDUES 1677-1991; COMPND 12 SYNONYM: NS4A, P8; COMPND 13 ENGINEERED: YES; COMPND 14 MOL_ID: 3; COMPND 15 MOLECULE: PEPTIDOMIMETIC INHIBITOR; COMPND 16 CHAIN: E, F; COMPND 17 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HEPATITIS C VIRUS (ISOLATE JAPANESE); SOURCE 3 ORGANISM_COMMON: HCV; SOURCE 4 ORGANISM_TAXID: 11116; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 MOL_ID: 2; SOURCE 8 ORGANISM_SCIENTIFIC: HEPATITIS C VIRUS (ISOLATE JAPANESE); SOURCE 9 ORGANISM_COMMON: HCV; SOURCE 10 ORGANISM_TAXID: 11116; SOURCE 11 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 12 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 13 MOL_ID: 3; SOURCE 14 SYNTHETIC: YES KEYWDS SERINE PROTEASE, NS3, NS4A, HEPATITIS C VIRUS, PROTEASE INHIBITION, KEYWDS 2 HYDROLASE-HYDROLASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR M.HAGEL,D.NIU,T.ST.MARTIN,M.P.SHEETS,L.QIAO,H.BERNARD,R.M.KARP,Z.ZHU, AUTHOR 2 M.T.LABENSKI,P.C.CHATURVEDI,M.NACHT,W.F.WESTLIN,R.C.PETTER,J.SINGH REVDAT 7 15-NOV-23 3OYP 1 LINK ATOM REVDAT 6 06-SEP-23 3OYP 1 REMARK SEQADV LINK REVDAT 5 31-JAN-18 3OYP 1 AUTHOR JRNL REVDAT 4 24-JAN-18 3OYP 1 JRNL REVDAT 3 19-DEC-12 3OYP 1 COMPND DBREF HET REMARK REVDAT 3 2 1 VERSN REVDAT 2 29-DEC-10 3OYP 1 JRNL REVDAT 1 01-DEC-10 3OYP 0 JRNL AUTH M.HAGEL,D.NIU,T.ST.MARTIN,M.P.SHEETS,L.QIAO,H.BERNARD, JRNL AUTH 2 R.M.KARP,Z.ZHU,M.T.LABENSKI,P.CHATURVEDI,M.NACHT, JRNL AUTH 3 W.F.WESTLIN,R.C.PETTER,J.SINGH JRNL TITL SELECTIVE IRREVERSIBLE INHIBITION OF A PROTEASE BY TARGETING JRNL TITL 2 A NONCATALYTIC CYSTEINE. JRNL REF NAT.CHEM.BIOL. V. 7 22 2011 JRNL REFN ISSN 1552-4450 JRNL PMID 21113170 JRNL DOI 10.1038/NCHEMBIO.492 REMARK 2 REMARK 2 RESOLUTION. 2.76 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0005 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.76 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 81.65 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 10158 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.219 REMARK 3 R VALUE (WORKING SET) : 0.215 REMARK 3 FREE R VALUE : 0.274 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 7.000 REMARK 3 FREE R VALUE TEST SET COUNT : 762 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.76 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.83 REMARK 3 REFLECTION IN BIN (WORKING SET) : 738 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.88 REMARK 3 BIN R VALUE (WORKING SET) : 0.3110 REMARK 3 BIN FREE R VALUE SET COUNT : 67 REMARK 3 BIN FREE R VALUE : 0.3520 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2815 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 2 REMARK 3 SOLVENT ATOMS : 10 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 36.83 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.18000 REMARK 3 B22 (A**2) : 0.18000 REMARK 3 B33 (A**2) : -0.27000 REMARK 3 B12 (A**2) : 0.09000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.408 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.319 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 16.216 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.914 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.849 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2878 ; 0.006 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 2687 ; 0.005 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3934 ; 1.181 ; 2.011 REMARK 3 BOND ANGLES OTHERS (DEGREES): 6224 ; 3.427 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 369 ; 5.522 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 90 ;27.592 ;21.778 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 436 ;15.943 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 24 ;13.551 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 459 ; 0.056 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3162 ; 0.003 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 558 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 574 ; 0.181 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 2707 ; 0.176 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 1417 ; 0.167 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): 1647 ; 0.082 ; 0.200 REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 86 ; 0.320 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): 2 ; 0.035 ; 0.200 REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 11 ; 0.095 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): 68 ; 0.145 ; 0.200 REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 4 ; 0.082 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2362 ; 1.195 ; 2.000 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 772 ; 0.156 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2984 ; 1.514 ; 3.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1213 ; 2.194 ; 4.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 938 ; 3.035 ; 6.000 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 3OYP COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 24-SEP-10. REMARK 100 THE DEPOSITION ID IS D_1000061738. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 04-DEC-09 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.2 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X06SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XDS, XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 10926 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.760 REMARK 200 RESOLUTION RANGE LOW (A) : 81.650 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.9 REMARK 200 DATA REDUNDANCY : 6.700 REMARK 200 R MERGE (I) : 0.12300 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.76 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.90 REMARK 200 COMPLETENESS FOR SHELL (%) : 92.6 REMARK 200 DATA REDUNDANCY IN SHELL : 6.90 REMARK 200 R MERGE FOR SHELL (I) : 0.64300 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: OTHER REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: 1DXP REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.11 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.51 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NACL, PH 5.2, VAPOR DIFFUSION, SITTING REMARK 280 DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 61 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 -X,-Y,Z+1/2 REMARK 290 5555 Y,-X+Y,Z+5/6 REMARK 290 6555 X-Y,X,Z+1/6 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 27.70967 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 55.41933 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 41.56450 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 69.27417 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 13.85483 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3650 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 8270 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -48.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C, E REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3710 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 8190 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -47.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, D, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 REMARK 400 THE N-PROPANOYL-D-ALANYL-(4R)-4-[(7-BROMOISOQUINOLIN-1-YL)OXY]-N-{ REMARK 400 (1R,2R)-1-[(CYCLOPROPYLSULFONYL)CARBAMOYL]-2-ETHENYLCYCLOPROPYL}-L- REMARK 400 PROLINAMIDE IS PEPTIDE-LIKE, A MEMBER OF ANTIVIRAL CLASS. REMARK 400 REMARK 400 GROUP: 1 REMARK 400 NAME: N-PROPANOYL-D-ALANYL-(4R)-4-[(7-BROMOISOQUINOLIN-1-YL)OXY]- REMARK 400 N-{(1R,2R)-1-[(CYCLOPROPYLSULFONYL)CARBAMOYL]-2- REMARK 400 ETHENYLCYCLOPROPYL}-L-PROLINAMIDE REMARK 400 CHAIN: E, F REMARK 400 COMPONENT_1: PEPTIDE LIKE POLYMER REMARK 400 DESCRIPTION: NULL REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ALA A 1 REMARK 465 GLU A 176 REMARK 465 THR A 177 REMARK 465 THR A 178 REMARK 465 MET A 179 REMARK 465 ARG A 180 REMARK 465 SER A 181 REMARK 465 PRO A 182 REMARK 465 VAL A 183 REMARK 465 PHE A 184 REMARK 465 THR A 185 REMARK 465 ASP A 186 REMARK 465 ASN A 187 REMARK 465 GLU B 176 REMARK 465 THR B 177 REMARK 465 THR B 178 REMARK 465 MET B 179 REMARK 465 ARG B 180 REMARK 465 SER B 181 REMARK 465 PRO B 182 REMARK 465 VAL B 183 REMARK 465 PHE B 184 REMARK 465 THR B 185 REMARK 465 ASP B 186 REMARK 465 ASN B 187 REMARK 465 LYS C 220 REMARK 465 GLY C 233 REMARK 465 ARG C 234 REMARK 465 LYS C 235 REMARK 465 LYS D 220 REMARK 465 GLY D 233 REMARK 465 ARG D 234 REMARK 465 LYS D 235 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 CYS B 145 CA - CB - SG ANGL. DEV. = 7.2 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 THR A 38 -157.92 -124.59 REMARK 500 CYS A 99 -26.80 -156.96 REMARK 500 THR B 38 -163.69 -123.76 REMARK 500 PHE B 43 -169.85 -165.60 REMARK 500 SER B 147 35.80 -97.47 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN A 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN B 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN E OF PEPTIDOMIMETIC REMARK 800 INHIBITOR REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN F OF PEPTIDOMIMETIC REMARK 800 INHIBITOR DBREF 3OYP A 1 187 UNP P26662 POLG_HCVJA 1027 1213 DBREF 3OYP B 1 187 UNP P26662 POLG_HCVJA 1027 1213 DBREF 3OYP C 221 234 UNP P26662 POLG_HCVJA 1677 1690 DBREF 3OYP D 221 234 UNP P26662 POLG_HCVJA 1677 1690 DBREF 3OYP E 1 5 PDB 3OYP 3OYP 1 5 DBREF 3OYP F 1 5 PDB 3OYP 3OYP 1 5 SEQADV 3OYP ILE A 114 UNP P26662 VAL 1140 VARIANT SEQADV 3OYP VAL A 132 UNP P26662 ILE 1158 VARIANT SEQADV 3OYP ILE B 114 UNP P26662 VAL 1140 VARIANT SEQADV 3OYP VAL B 132 UNP P26662 ILE 1158 VARIANT SEQADV 3OYP LYS C 220 UNP P26662 EXPRESSION TAG SEQADV 3OYP LYS C 235 UNP P26662 EXPRESSION TAG SEQADV 3OYP LYS D 220 UNP P26662 EXPRESSION TAG SEQADV 3OYP LYS D 235 UNP P26662 EXPRESSION TAG SEQRES 1 A 187 ALA PRO ILE THR ALA TYR SER GLN GLN THR ARG GLY LEU SEQRES 2 A 187 LEU GLY CYS ILE ILE THR SER LEU THR GLY ARG ASP LYS SEQRES 3 A 187 ASN GLN VAL ASP GLY GLU VAL GLN VAL LEU SER THR ALA SEQRES 4 A 187 THR GLN SER PHE LEU ALA THR CYS VAL ASN GLY VAL CYS SEQRES 5 A 187 TRP THR VAL TYR HIS GLY ALA GLY SER LYS THR LEU ALA SEQRES 6 A 187 GLY PRO LYS GLY PRO ILE THR GLN MET TYR THR ASN VAL SEQRES 7 A 187 ASP GLN ASP LEU VAL GLY TRP PRO ALA PRO PRO GLY ALA SEQRES 8 A 187 ARG SER MET THR PRO CYS THR CYS GLY SER SER ASP LEU SEQRES 9 A 187 TYR LEU VAL THR ARG HIS ALA ASP VAL ILE PRO VAL ARG SEQRES 10 A 187 ARG ARG GLY ASP SER ARG GLY SER LEU LEU SER PRO ARG SEQRES 11 A 187 PRO VAL SER TYR LEU LYS GLY SER SER GLY GLY PRO LEU SEQRES 12 A 187 LEU CYS PRO SER GLY HIS VAL VAL GLY ILE PHE ARG ALA SEQRES 13 A 187 ALA VAL CYS THR ARG GLY VAL ALA LYS ALA VAL ASP PHE SEQRES 14 A 187 ILE PRO VAL GLU SER MET GLU THR THR MET ARG SER PRO SEQRES 15 A 187 VAL PHE THR ASP ASN SEQRES 1 B 187 ALA PRO ILE THR ALA TYR SER GLN GLN THR ARG GLY LEU SEQRES 2 B 187 LEU GLY CYS ILE ILE THR SER LEU THR GLY ARG ASP LYS SEQRES 3 B 187 ASN GLN VAL ASP GLY GLU VAL GLN VAL LEU SER THR ALA SEQRES 4 B 187 THR GLN SER PHE LEU ALA THR CYS VAL ASN GLY VAL CYS SEQRES 5 B 187 TRP THR VAL TYR HIS GLY ALA GLY SER LYS THR LEU ALA SEQRES 6 B 187 GLY PRO LYS GLY PRO ILE THR GLN MET TYR THR ASN VAL SEQRES 7 B 187 ASP GLN ASP LEU VAL GLY TRP PRO ALA PRO PRO GLY ALA SEQRES 8 B 187 ARG SER MET THR PRO CYS THR CYS GLY SER SER ASP LEU SEQRES 9 B 187 TYR LEU VAL THR ARG HIS ALA ASP VAL ILE PRO VAL ARG SEQRES 10 B 187 ARG ARG GLY ASP SER ARG GLY SER LEU LEU SER PRO ARG SEQRES 11 B 187 PRO VAL SER TYR LEU LYS GLY SER SER GLY GLY PRO LEU SEQRES 12 B 187 LEU CYS PRO SER GLY HIS VAL VAL GLY ILE PHE ARG ALA SEQRES 13 B 187 ALA VAL CYS THR ARG GLY VAL ALA LYS ALA VAL ASP PHE SEQRES 14 B 187 ILE PRO VAL GLU SER MET GLU THR THR MET ARG SER PRO SEQRES 15 B 187 VAL PHE THR ASP ASN SEQRES 1 C 16 LYS GLY SER VAL VAL ILE VAL GLY ARG ILE ILE LEU SER SEQRES 2 C 16 GLY ARG LYS SEQRES 1 D 16 LYS GLY SER VAL VAL ILE VAL GLY ARG ILE ILE LEU SER SEQRES 2 D 16 GLY ARG LYS SEQRES 1 E 5 PPI DAL 0Y8 0Y9 0YA SEQRES 1 F 5 PPI DAL 0Y8 0Y9 0YA MODRES 3OYP 0Y8 E 3 PRO MODRES 3OYP 0Y8 F 3 PRO HET PPI E 1 4 HET DAL E 2 5 HET 0Y8 E 3 19 HET 0Y9 E 4 8 HET 0YA E 5 7 HET PPI F 1 4 HET DAL F 2 5 HET 0Y8 F 3 19 HET 0Y9 F 4 8 HET 0YA F 5 7 HET ZN A 201 1 HET ZN B 201 1 HETNAM PPI PROPANOIC ACID HETNAM DAL D-ALANINE HETNAM 0Y8 (4R)-4-[(7-BROMOISOQUINOLIN-1-YL)OXY]-L-PROLINE HETNAM 0Y9 (1R,2S)-1-AMINO-2-ETHENYLCYCLOPROPANECARBOXYLIC ACID HETNAM 0YA CYCLOPROPANESULFONAMIDE HETNAM ZN ZINC ION FORMUL 5 PPI 2(C3 H6 O2) FORMUL 5 DAL 2(C3 H7 N O2) FORMUL 5 0Y8 2(C14 H13 BR N2 O3) FORMUL 5 0Y9 2(C6 H9 N O2) FORMUL 5 0YA 2(C3 H7 N O2 S) FORMUL 7 ZN 2(ZN 2+) FORMUL 9 HOH *10(H2 O) HELIX 1 1 GLY A 12 GLY A 23 1 12 HELIX 2 2 VAL A 55 GLY A 60 1 6 HELIX 3 3 VAL A 132 LYS A 136 1 5 HELIX 4 4 GLU A 173 MET A 175 5 3 HELIX 5 5 GLY B 12 GLY B 23 1 12 HELIX 6 6 TYR B 56 GLY B 60 1 5 HELIX 7 7 VAL B 132 LYS B 136 1 5 HELIX 8 8 GLU B 173 MET B 175 5 3 SHEET 1 A 7 THR A 4 GLN A 9 0 SHEET 2 A 7 VAL C 224 SER C 232 -1 O SER C 232 N THR A 4 SHEET 3 A 7 VAL A 33 SER A 37 -1 N VAL A 35 O GLY C 227 SHEET 4 A 7 SER A 42 CYS A 47 -1 O PHE A 43 N LEU A 36 SHEET 5 A 7 VAL A 51 THR A 54 -1 O TRP A 53 N THR A 46 SHEET 6 A 7 LEU A 82 PRO A 86 -1 O VAL A 83 N THR A 54 SHEET 7 A 7 TYR A 75 ASN A 77 -1 N ASN A 77 O LEU A 82 SHEET 1 B 2 LEU A 64 ALA A 65 0 SHEET 2 B 2 PRO A 70 ILE A 71 -1 O ILE A 71 N LEU A 64 SHEET 1 C 7 ASP A 103 VAL A 107 0 SHEET 2 C 7 VAL A 113 GLY A 120 -1 O ILE A 114 N LEU A 106 SHEET 3 C 7 ARG A 123 PRO A 131 -1 O SER A 125 N ARG A 117 SHEET 4 C 7 VAL A 163 PRO A 171 -1 O VAL A 167 N GLY A 124 SHEET 5 C 7 VAL A 150 THR A 160 -1 N ALA A 156 O ASP A 168 SHEET 6 C 7 PRO A 142 LEU A 144 -1 N LEU A 143 O VAL A 151 SHEET 7 C 7 ASP A 103 VAL A 107 -1 N TYR A 105 O LEU A 144 SHEET 1 D 7 THR B 4 GLN B 9 0 SHEET 2 D 7 VAL D 224 SER D 232 -1 O ARG D 228 N GLN B 8 SHEET 3 D 7 VAL B 33 SER B 37 -1 N VAL B 35 O VAL D 226 SHEET 4 D 7 SER B 42 CYS B 47 -1 O ALA B 45 N GLN B 34 SHEET 5 D 7 VAL B 51 VAL B 55 -1 O TRP B 53 N THR B 46 SHEET 6 D 7 LEU B 82 PRO B 86 -1 O VAL B 83 N THR B 54 SHEET 7 D 7 TYR B 75 ASN B 77 -1 N ASN B 77 O LEU B 82 SHEET 1 E 2 LEU B 64 GLY B 66 0 SHEET 2 E 2 GLY B 69 ILE B 71 -1 O ILE B 71 N LEU B 64 SHEET 1 F 7 ASP B 103 VAL B 107 0 SHEET 2 F 7 VAL B 113 ARG B 118 -1 O VAL B 116 N LEU B 104 SHEET 3 F 7 ARG B 123 PRO B 131 -1 O SER B 125 N ARG B 117 SHEET 4 F 7 VAL B 163 PRO B 171 -1 O ALA B 164 N ARG B 130 SHEET 5 F 7 HIS B 149 THR B 160 -1 N ALA B 156 O ASP B 168 SHEET 6 F 7 PRO B 142 CYS B 145 -1 N CYS B 145 O HIS B 149 SHEET 7 F 7 ASP B 103 VAL B 107 -1 N TYR B 105 O LEU B 144 SSBOND 1 CYS B 99 CYS B 145 1555 1555 2.06 LINK SG CYS A 159 C3 PPI E 1 1555 1555 1.81 LINK SG CYS B 159 C3 PPI F 1 1555 1555 1.81 LINK C1 PPI E 1 N DAL E 2 1555 1555 1.39 LINK C DAL E 2 N 0Y8 E 3 1555 1555 1.41 LINK C 0Y8 E 3 N 0Y9 E 4 1555 1555 1.39 LINK C 0Y9 E 4 N28 0YA E 5 1555 1555 1.38 LINK C1 PPI F 1 N DAL F 2 1555 1555 1.38 LINK C DAL F 2 N 0Y8 F 3 1555 1555 1.41 LINK C 0Y8 F 3 N 0Y9 F 4 1555 1555 1.38 LINK C 0Y9 F 4 N28 0YA F 5 1555 1555 1.38 SITE 1 AC1 4 CYS A 97 CYS A 99 CYS A 145 HOH A 305 SITE 1 AC2 4 CYS B 97 THR B 98 CYS B 99 CYS B 145 SITE 1 AC3 16 GLN A 41 PHE A 43 HIS A 57 GLY A 58 SITE 2 AC3 16 ASP A 81 VAL A 132 LEU A 135 LYS A 136 SITE 3 AC3 16 GLY A 137 SER A 138 SER A 139 PHE A 154 SITE 4 AC3 16 ARG A 155 ALA A 156 ALA A 157 CYS A 159 SITE 1 AC4 15 GLN B 41 SER B 42 PHE B 43 HIS B 57 SITE 2 AC4 15 ASP B 81 LEU B 135 LYS B 136 GLY B 137 SITE 3 AC4 15 SER B 138 SER B 139 PHE B 154 ARG B 155 SITE 4 AC4 15 ALA B 156 ALA B 157 CYS B 159 CRYST1 94.401 94.401 83.129 90.00 90.00 120.00 P 61 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010593 0.006116 0.000000 0.00000 SCALE2 0.000000 0.012232 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012029 0.00000